The global Sepsis Diagnostics Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sepsis Diagnostics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Diagnostics Testing.
Report Scope
The Sepsis Diagnostics Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Diagnostics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Diagnostics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Axis Shield
Becton Dickinson
bioMérieux
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific
Segment by Type
Point-of-Care Testing
Laboratory Testing
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Diagnostics Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostics Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Point-of-Care Testing
1.2.3 Laboratory Testing
1.3 Market by Application
1.3.1 Global Sepsis Diagnostics Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostics Testing Market Perspective (2019-2030)
2.2 Sepsis Diagnostics Testing Growth Trends by Region
2.2.1 Global Sepsis Diagnostics Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sepsis Diagnostics Testing Historic Market Size by Region (2019-2024)
2.2.3 Sepsis Diagnostics Testing Forecasted Market Size by Region (2025-2030)
2.3 Sepsis Diagnostics Testing Market Dynamics
2.3.1 Sepsis Diagnostics Testing Industry Trends
2.3.2 Sepsis Diagnostics Testing Market Drivers
2.3.3 Sepsis Diagnostics Testing Market Challenges
2.3.4 Sepsis Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostics Testing Players by Revenue
3.1.1 Global Top Sepsis Diagnostics Testing Players by Revenue (2019-2024)
3.1.2 Global Sepsis Diagnostics Testing Revenue Market Share by Players (2019-2024)
3.2 Global Sepsis Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostics Testing Revenue
3.4 Global Sepsis Diagnostics Testing Market Concentration Ratio
3.4.1 Global Sepsis Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostics Testing Revenue in 2023
3.5 Sepsis Diagnostics Testing Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostics Testing Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostics Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostics Testing Breakdown Data by Type
4.1 Global Sepsis Diagnostics Testing Historic Market Size by Type (2019-2024)
4.2 Global Sepsis Diagnostics Testing Forecasted Market Size by Type (2025-2030)
5 Sepsis Diagnostics Testing Breakdown Data by Application
5.1 Global Sepsis Diagnostics Testing Historic Market Size by Application (2019-2024)
5.2 Global Sepsis Diagnostics Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sepsis Diagnostics Testing Market Size (2019-2030)
6.2 North America Sepsis Diagnostics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sepsis Diagnostics Testing Market Size by Country (2019-2024)
6.4 North America Sepsis Diagnostics Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostics Testing Market Size (2019-2030)
7.2 Europe Sepsis Diagnostics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sepsis Diagnostics Testing Market Size by Country (2019-2024)
7.4 Europe Sepsis Diagnostics Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Testing Market Size (2019-2030)
8.2 Asia-Pacific Sepsis Diagnostics Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Sepsis Diagnostics Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostics Testing Market Size (2019-2030)
9.2 Latin America Sepsis Diagnostics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sepsis Diagnostics Testing Market Size by Country (2019-2024)
9.4 Latin America Sepsis Diagnostics Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Testing Market Size (2019-2030)
10.2 Middle East & Africa Sepsis Diagnostics Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Sepsis Diagnostics Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Sepsis Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Axis Shield
11.2.1 Axis Shield Company Detail
11.2.2 Axis Shield Business Overview
11.2.3 Axis Shield Sepsis Diagnostics Testing Introduction
11.2.4 Axis Shield Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.2.5 Axis Shield Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Sepsis Diagnostics Testing Introduction
11.3.4 Becton Dickinson Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Detail
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Sepsis Diagnostics Testing Introduction
11.4.4 bioMérieux Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.4.5 bioMérieux Recent Development
11.5 Bruker
11.5.1 Bruker Company Detail
11.5.2 Bruker Business Overview
11.5.3 Bruker Sepsis Diagnostics Testing Introduction
11.5.4 Bruker Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.5.5 Bruker Recent Development
11.6 Cytosorbents
11.6.1 Cytosorbents Company Detail
11.6.2 Cytosorbents Business Overview
11.6.3 Cytosorbents Sepsis Diagnostics Testing Introduction
11.6.4 Cytosorbents Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.6.5 Cytosorbents Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher Sepsis Diagnostics Testing Introduction
11.7.4 Danaher Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.7.5 Danaher Recent Development
11.8 Immunexpress
11.8.1 Immunexpress Company Detail
11.8.2 Immunexpress Business Overview
11.8.3 Immunexpress Sepsis Diagnostics Testing Introduction
11.8.4 Immunexpress Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.8.5 Immunexpress Recent Development
11.9 Luminex
11.9.1 Luminex Company Detail
11.9.2 Luminex Business Overview
11.9.3 Luminex Sepsis Diagnostics Testing Introduction
11.9.4 Luminex Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.9.5 Luminex Recent Development
11.10 Mitsubishi Chemical
11.10.1 Mitsubishi Chemical Company Detail
11.10.2 Mitsubishi Chemical Business Overview
11.10.3 Mitsubishi Chemical Sepsis Diagnostics Testing Introduction
11.10.4 Mitsubishi Chemical Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.10.5 Mitsubishi Chemical Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Diagnostics Testing Introduction
11.11.4 Response Biomedical Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.11.5 Response Biomedical Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche Sepsis Diagnostics Testing Introduction
11.12.4 Roche Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.12.5 Roche Recent Development
11.13 T2 Biosystems
11.13.1 T2 Biosystems Company Detail
11.13.2 T2 Biosystems Business Overview
11.13.3 T2 Biosystems Sepsis Diagnostics Testing Introduction
11.13.4 T2 Biosystems Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.13.5 T2 Biosystems Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Detail
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Sepsis Diagnostics Testing Introduction
11.14.4 Thermo Fisher Scientific Revenue in Sepsis Diagnostics Testing Business (2019-2024)
11.14.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott
Axis Shield
Becton Dickinson
bioMérieux
Bruker
Cytosorbents
Danaher
Immunexpress
Luminex
Mitsubishi Chemical
Response Biomedical
Roche
T2 Biosystems
Thermo Fisher Scientific
*If Applicable.